徐浩宇：现任扬子江药业集团党委书记、董事长兼总经理，全国工商联医药业商会副会长，中国医药质量管理协会副会长，江苏省工商业联合会副会长，江苏省苏商发展促进会常务副会长，江苏省医药行业协会会长，曾荣获中国长三角十大杰出青商、全国QC优秀质量负责人、“十三五”苏商未来之星等称号。

从管理者到药企掌门人，他华丽转身大刀阔斧推进改革，通过战略重构、机制创新和文化重塑，开启扬子江 “二次创业”新征程；他全力打造“化、中、生+药、医、养、食、游”双品牌战略，以“健康中国”为引领，为集团高质量发展锚定方向；他聚焦品质升级，持续守正创新，带领扬子江药业朝着世界一流制药企业迈进。

Mr. Xu Haoyu is currently the Secretary of the Party Committee, Chairman and General Manager of Yangtze River Pharmaceutical Group, Vice President of All-China Federation of Industry & Commerce Medical & Pharmaceutical Industry Chamber, Vice President of China Quality Association for Pharmaceuticals, Vice President of Jiangsu Federation of Industry and Commerce, Executive Vice President of Jiangsu Sushang Development Promotion Association, and President of Jiangsu Provincial Pharmacy Association. He has been awarded as one of the Top 10 Outstanding Young Entrepreneurs in Yangtze River Delta, National QC Excellent Quality Person, and Future Star of Jiangsu Entrepreneurs in the Thirteenth Five-Year Plan., etc.

From an executive to the person in charge of a pharmaceutical group, he has made a gorgeous turn to deepen reform, and to start a new journey of Yangtze River Pharmaceutical Group through strategic restructuring, mechanism innovation and cultural reshaping; he has made every effort to build dual brand strategy of “Chemical Medicines, Traditional Chinese Medicines, Biological Medicines + Medicines, Medical Care, Health Preserving, Food, Tourism” to set the direction for the Group’s high-quality development under the guidance of Healthy China; focusing on quality upgrading, upholding fundamental principles and breaking new ground, he is leading Yangtze River Pharmaceutical Group to move towards a world-class pharmaceutical enterprise.